| dc.contributor.author | Ozaras R. | |
| dc.contributor.author | Leblebicioglu H. | |
| dc.date.accessioned | 2020-06-21T09:28:07Z | |
| dc.date.available | 2020-06-21T09:28:07Z | |
| dc.date.issued | 2009 | |
| dc.identifier.issn | 1476-0711 | |
| dc.identifier.uri | https://doi.org/10.1186/1476-0711-8-6 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/4244 | |
| dc.description | PubMed: 19254373 | en_US |
| dc.description.abstract | [No abstract available] | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.isversionof | 10.1186/1476-0711-8-6 | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | How to compare antivirals in the treatment of chronic hepatitis B? | en_US |
| dc.type | editorial | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 8 | en_US |
| dc.relation.journal | Annals of Clinical Microbiology and Antimicrobials | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
